Guideline Current FIGO 2018

FIGO 2018 Cervical Cancer Staging

FIGO 2018 revised staging system for cervical carcinoma. Incorporates MRI-derived tumor size, parametrial invasion, pelvic side-wall involvement, and nodal disease.

Structured reportUpdated Jul 5, 2026
Applies to
  • Biopsy-proven cervical carcinoma undergoing staging
Classification
  • FIGO stage I
  • FIGO stage II
  • FIGO stage III
  • FIGO stage IV
Exclusions

None listed

Interactive

Decision tree

Enter a finding to compute a recommendation without leaving the page.

Recommendation builder

Select the FIGO 2018 stage derived from MRI and clinical assessment.

FAQ

Frequently asked

Does this guideline apply to oncology patients?

No — patients with known malignancy fall outside the scope unless the guideline states otherwise. Follow oncologic surveillance protocols instead.